SCHEMBL8959652

SCHEMBL8959652

CC(C)c1cc2c(ccn2C[C@@](C)(N)OC(=O)/C=C/C(=O)O[C@](C)(N)Cn2ccc3cc(F)c(C(C)C)cc32)cc1F

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 9/20 0.40
HTR2A P28223 8/20 0.40
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
HTR2B P41595 1/20 0.37
THRA P10827 1/20 0.32
THRB P10828 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
POLB P06746 1/20 0.32
HPGD P15428 1/20 0.32
APOBEC3A P31941 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HSD17B10 Q99714 1/20 0.32
APOBEC3G Q9HC16 1/20 0.32
AR P10275 2/20 0.32
EIF4A3 P38919 1/20 0.32
NPY5R Q15761 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8959608 0.89 HTR2A (0.45) HTR2CHTR2ACYP1A2CYP3A4CYP2C9
SCHEMBL8959561 0.85 HTR2A (0.49) HTR2CHTR2ACYP1A2CYP3A4CYP2C9
SCHEMBL27363223 0.85 HTR2A (0.49) HTR2CHTR2ACYP1A2CYP3A4CYP2C9
SCHEMBL8959713 0.85 HTR2A (0.49) HTR2CHTR2ACYP1A2CYP3A4CYP2C9
SCHEMBL8959551 0.84 AR (0.39) HTR2CHTR2ACYP1A2CYP3A4CYP2C9
SCHEMBL8959864 0.83 HTR2A (0.49) HTR2CHTR2ACYP1A2CYP3A4CYP2C9
SCHEMBL8959678 0.81 HTR2C (0.46) HTR2CHTR2AARNPY5R
SCHEMBL8959562 0.81 HTR2C (0.46) HTR2CHTR2AARNPY5R
SCHEMBL8959479 0.81 HTR2C (0.46) HTR2CHTR2AARNPY5R
SCHEMBL27356666 0.81 HTR2C (0.46) HTR2CHTR2AARNPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5494928-A FOR CENTRAL NERVOUS SYSTEM DISORDERS, BLOCKING SEROTONIN RECEPTORS, ANTIDEPRESSANTS HOFFMANN-LA ROCHE INC. (US) 1996-02-27 US disclosed